Next Article in Journal
Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein
Next Article in Special Issue
Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates
Previous Article in Journal
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
Previous Article in Special Issue
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2
 
 
Article

Article Versions Notes

Vaccines 2024, 12(5), 448; https://doi.org/10.3390/vaccines12050448
Action Date Notes Link
article pdf uploaded. 23 April 2024 14:26 CEST Version of Record https://www.mdpi.com/2076-393X/12/5/448/pdf-vor
article supplementary file uploaded. 23 April 2024 14:26 CEST - https://www.mdpi.com/2076-393X/12/5/448#supplementary
article xml file uploaded 25 April 2024 13:03 CEST Original file -
article xml uploaded. 25 April 2024 13:03 CEST Update https://www.mdpi.com/2076-393X/12/5/448/xml
article pdf uploaded. 25 April 2024 13:03 CEST Updated version of record https://www.mdpi.com/2076-393X/12/5/448/pdf
article html file updated 25 April 2024 13:07 CEST Original file https://www.mdpi.com/2076-393X/12/5/448/html
Back to TopTop